Patents by Inventor Kaj Stenlöf

Kaj Stenlöf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sultiame for the treatment of sleep apnea
    Patent number: 10617694
    Abstract: There is provided for novel therapy of sleep apnea that involves administering the drug sultiame to the patient.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: April 14, 2020
    Inventors: Jan Hedner, Ludger Grote, Kaj Stenlöf
  • SULTIAME FOR THE TREATMENT OF SLEEP APNEA
    Publication number: 20190201411
    Abstract: There is provided for novel therapy of sleep apnea that involves administering the drug sultiame to the patient.
    Type: Application
    Filed: May 9, 2017
    Publication date: July 4, 2019
    Inventors: Jan Hedner, Ludger Grote, Kaj Stenlöf
  • Method of treating sleep disordered breathing using topiramate
    Patent number: 7981443
    Abstract: A method for treating snoring, sleep apnoea and other forms of sleep disordered breathing involves administration to a patient of a therapeutically effective amount of topiramate over an appropriate period of time, such as a period substantially coinciding with the sleep period of a patient. A useful route of administration is per os. Also disclosed is the use of topiramate for the diagnosis of snoring, sleep apnoea and other forms of sleep disordered breathing.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: July 19, 2011
    Inventors: Jan Hedner, Lars Sjöström, Kaj Stenlöf, Ludger Grote
  • Methods for treating a patient having Metabolic Syndrome
    Patent number: 7122515
    Abstract: A method for treating a patient having Metabolic Syndrome comprising Primary Insulin Resistance and exhibiting lipoprotein aberrations or hypertension comprises administering to said patient human growth hormone or a functional analog thereof in an amount effective for decreasing lipoprotein aberrations or hypertension of said patient.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: October 17, 2006
    Assignee: Pharmacia AB
    Inventors: Gudmundur Johannsson, Per M{dot over (a)}rin, Lars Lönn, Malin Ottosson, Kaj Stenlöf, Per Björntorp, Lars Sjöström, Bengt-{dot over (A)}ke Bengtsson
  • Method for treating a patient having metabolic syndrome
    Patent number: 6846800
    Abstract: Methods for treating a patient for insulin resistance to decrease the insulin resistance in a patient having Metabolic Syndrome comprising Primary Insulin Resistance and abdominal/visceral obesity comprise administering to the patient growth hormone or a functional derivative thereof in an amount effective for decreasing insulin resistance of the patient.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: January 25, 2005
    Assignee: Pharmacia AB
    Inventors: Gudmundur Johannsson, Per Mårin, Lars Lönn, Malin Ottosson, Kaj Stenlöf, Per Björntorp, Lars Sjöström, Bengt-Åke Bengtsson